Type I Interferons in Newborns—Neurotoxicity versus Antiviral Defense
ABSTRACT In most children and adults, primary infection with herpes simplex virus 1 (HSV-1) is asymptomatic. However, very rarely (incidence of 1 in 1,000,000), it can cause herpes simplex encephalitis (HSE). HSE also occurs in infants but with a much starker incidence of one in three. This age diff...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/96050b9a6dd94199896d0c95674d0d37 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:96050b9a6dd94199896d0c95674d0d37 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:96050b9a6dd94199896d0c95674d0d372021-11-15T15:50:17ZType I Interferons in Newborns—Neurotoxicity versus Antiviral Defense10.1128/mBio.00639-162150-7511https://doaj.org/article/96050b9a6dd94199896d0c95674d0d372016-07-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00639-16https://doaj.org/toc/2150-7511ABSTRACT In most children and adults, primary infection with herpes simplex virus 1 (HSV-1) is asymptomatic. However, very rarely (incidence of 1 in 1,000,000), it can cause herpes simplex encephalitis (HSE). HSE also occurs in infants but with a much starker incidence of one in three. This age difference in susceptibility to HSV-1-caused HSE is not well understood. In a recent article in mBio, authors have identified the choroid plexus as the anatomical site of robust HSV-1 replication in the brain. They point to low levels of type I interferon (IFN) receptor as causal of the lack of HSV-1 replication control in neonates, in contrast to adults. Here, I discuss these findings in the context of human genetic evidence. I point to the balancing act of type I IFN acting as a neurotoxin and an antiviral agent, an evolutionary choice of a lesser evil.Dusan BogunovicAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 7, Iss 3 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Microbiology QR1-502 |
spellingShingle |
Microbiology QR1-502 Dusan Bogunovic Type I Interferons in Newborns—Neurotoxicity versus Antiviral Defense |
description |
ABSTRACT In most children and adults, primary infection with herpes simplex virus 1 (HSV-1) is asymptomatic. However, very rarely (incidence of 1 in 1,000,000), it can cause herpes simplex encephalitis (HSE). HSE also occurs in infants but with a much starker incidence of one in three. This age difference in susceptibility to HSV-1-caused HSE is not well understood. In a recent article in mBio, authors have identified the choroid plexus as the anatomical site of robust HSV-1 replication in the brain. They point to low levels of type I interferon (IFN) receptor as causal of the lack of HSV-1 replication control in neonates, in contrast to adults. Here, I discuss these findings in the context of human genetic evidence. I point to the balancing act of type I IFN acting as a neurotoxin and an antiviral agent, an evolutionary choice of a lesser evil. |
format |
article |
author |
Dusan Bogunovic |
author_facet |
Dusan Bogunovic |
author_sort |
Dusan Bogunovic |
title |
Type I Interferons in Newborns—Neurotoxicity versus Antiviral Defense |
title_short |
Type I Interferons in Newborns—Neurotoxicity versus Antiviral Defense |
title_full |
Type I Interferons in Newborns—Neurotoxicity versus Antiviral Defense |
title_fullStr |
Type I Interferons in Newborns—Neurotoxicity versus Antiviral Defense |
title_full_unstemmed |
Type I Interferons in Newborns—Neurotoxicity versus Antiviral Defense |
title_sort |
type i interferons in newborns—neurotoxicity versus antiviral defense |
publisher |
American Society for Microbiology |
publishDate |
2016 |
url |
https://doaj.org/article/96050b9a6dd94199896d0c95674d0d37 |
work_keys_str_mv |
AT dusanbogunovic typeiinterferonsinnewbornsneurotoxicityversusantiviraldefense |
_version_ |
1718427414194814976 |